Metformin

Yes1 associated transcriptional regulator ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35264157 Novel sequential therapy with metformin enhances the effects of cisplatin in testicular germ cell tumours via YAP1 signalling. 2022 Mar 9 3
2 33487223 Retraction notice to 'The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC' [EBioMedicine 37 (2018) 188-204]. 2021 Jan 2
3 33650651 Metformin inhibits mTOR and c-Myc by decreasing YAP protein expression in OSCC cells. 2021 Mar 10
4 34298652 Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer. 2021 Jul 9 1
5 31897243 Metformin and LW6 impairs pancreatic cancer cells and reduces nuclear localization of YAP1. 2020 3
6 31906986 Metformin-repressed miR-381-YAP-snail axis activity disrupts NSCLC growth and metastasis. 2020 Jan 6 5
7 32281270 Metformin suppresses proliferation and invasion of drug-resistant breast cancer cells by activation of the Hippo pathway. 2020 May 2
8 32407182 The effects of metformin on the hippo pathway in the proliferation of melanoma cancer cells: a preclinical study. 2020 May 14 3
9 32991321 D-galactose induces senescence of glioblastoma cells through YAP-CDK6 pathway. 2020 Sep 29 1
10 31455378 Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells. 2019 Aug 27 7
11 31814900 Metformin attenuates PD-L1 expression through activating Hippo signaling pathway in colorectal cancer cells. 2019 4
12 29567539 Metformin inhibits glioma cells stemness and epithelial-mesenchymal transition via regulating YAP activity. 2018 Jun 6
13 30389502 The antineoplastic drug metformin downregulates YAP by interfering with IRF-1 binding to the YAP promoter in NSCLC. 2018 Nov 8
14 27323827 Metformin mediates resensitivity to 5-fluorouracil in hepatocellular carcinoma via the suppression of YAP. 2016 Jul 19 4